Search results for “Ubiquitin-Proteasomal Pathway” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 59 patents, we discovered top 15 key players by total patent application. C4 Therapeutics, Inc., Nurix Therapeutics, Inc., Gilead Sciences, Inc. are dominant in this area. They take 66.10% of the total patent filing.
C4 Therapeutics, Inc.
Massachusetts, United States
Patent: 16
Nurix Therapeutics, Inc.
California, United States
Patent: 12
Gilead Sciences, Inc.
California, United States
Patent: 11
Das CeMM - Forschungszentrum für Molekulare Medizin GmbH
Wien, Austria
Patent: 4
ProScript, Inc.
Massachusetts, United States
Patent: 2
Arizona Board of Regents
Arizona, United States
Patent: 1
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
FORMA Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Myogen, Inc.
Colorado, United States
Patent: 1
STARTUP
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 54 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing C4 Therapeutics, Inc., Nurix Therapeutics, Inc., Gilead Sciences, Inc. take 72.22% of patent filing during this period.
C4 Therapeutics, Inc.
Massachusetts, United States
Patent: 16
Nurix Therapeutics, Inc.
California, United States
Patent: 12
Gilead Sciences, Inc.
California, United States
Patent: 11
Das CeMM - Forschungszentrum für Molekulare Medizin GmbH
Wien, Austria
Patent: 4
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 1
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
Chongqing University
Chongqing Shi, China
Patent: 1
Shandong University
Shandong Sheng, China
Patent: 1
STARTUP
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 54 patents in last 5 years, we discover 18 new entrants. C4 Therapeutics, Inc., Nurix Therapeutics, Inc., Gilead Sciences, Inc. are the most active new entrants in this area.
C4 Therapeutics, Inc.
Massachusetts, United States
Patent: 16
Nurix Therapeutics, Inc.
California, United States
Patent: 12
Gilead Sciences, Inc.
California, United States
Patent: 11
Das CeMM - Forschungszentrum für Molekulare Medizin GmbH
Wien, Austria
Patent: 4
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 1
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
Chongqing University
Chongqing Shi, China
Patent: 1
Shandong University
Shandong Sheng, China
Patent: 1
STARTUP
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 13 patents, we discovered top 9 universities and scientific research institutions by total patent application. New York University, Massachusetts Institute of Technology, Shandong University are dominant in this area. They take 38.46% of the total patent filing.
New York University
New York, United States
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 1
Shandong University
Shandong Sheng, China
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Southern Medical University
Guangdong Sheng, China
Patent: 1
Yangzhou University
Jiangsu Sheng, China
Patent: 1
The Second Military Medical University
Shanghai Shi, China
Patent: 1
Chongqing University
Chongqing Shi, China
Patent: 1
Soochow University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: